About us
Taipei Bioinnovation Park is Taiwan's first focused BOT development project for the biotech industry. Spanning over 1.5 hectares, the park houses a nearly 30,000-ping biotech building with integrated R&D, pilot production, and business spaces. It serves as a key core base, promoting nationwide biotech integration and international collaboration while nurturing talent and fostering innovation.
Introduction to TBIP
Taipei Bioinnovation Park, inaugurated in 2023, is strategically located in the Nan-Kang Biotech Industry Axis. Its site offers the advantages of a strategic position, convenient transportation, and a convergence of industries.
Positioned adjacent to prominent biotech and pharmaceutical research centers like the National Research Institute and the National Biotechnology Research Park on the south side, it also links to existing medical facilities and technology parks on the north side, and it is regulated by the health and welfare authority for the biotech industry on the west side.
The park serves as a cornerstone in Taiwan's biotechnology landscape, fostering growth and collaboration.
Development Team of TBIP
The Taipei Bioinnovation Park is a focal point for Taiwan's biotechnology industry. Recognizing the importance of biotech industry development for Taiwan's future, the park's comprehensive planning is carried out by the Formosa Biomedical Technology Corp., which has long cooperated with the government's policies for promoting high-tech industries.
The company has successfully brought together over 400 domestic and international firms, generating significant value. The park's subsidiary, Sino-Kang Development Corp., under the leadership of Chairman Huang Mao-Hsiung and a professional team, aims to replicate the successful experience of the Nangang Software Park and create a core engine for Taiwan's biotechnology industry cluster corridor.
Contact US
